The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture

Cancer Letters
Elizabeth M Haley, Yonghyun Kim

Abstract

Glioblastoma multiforme (GBM) is the most malignant form of central nervous system tumor, and current therapies are largely ineffective at treating the cancer. Developing a more complete understanding of the mechanisms controlling the tumor is important in order to explore new possible treatment options. It is speculated that the presence of glioblastoma stem or stem-like cells (GSCs), a rare type of pluripotent cancer cell that possesses the ability to self-renew and generate tumors, could be an important factor contributing to the resistance to treatment and deadliness of the cancer. A comprehensive knowledge of the mechanisms controlling the expression and properties of GSCs is currently lacking, and one promising area for further exploration is in the influence of basic fibroblast growth factor (FGF-2) on GSCs. Recent studies reveal that FGF-2 plays a significant part in regulating GBM, and the growth factor is commonly included as a supplement in media used to culture GSCs in vitro. However, the particular role that FGF-2 plays in GSCs has not been as extensively explored. Therefore, understanding how FGF-2 is involved in GSCs and in GBMs could be an important step towards a more complete comprehension of the managing the ...Continue Reading

References

Jan 1, 1986·Cold Spring Harbor Symposia on Quantitative Biology·J A AbrahamJ C Fiddes
Dec 10, 1999·Nature Biotechnology·M D BallingerW M Kavanaugh
Oct 6, 2000·Endocrine-related Cancer·C J PowersA Wellstein
Nov 2, 2001·Nature·T ReyaI L Weissman
Jun 29, 2002·Circulation Research·Ichiro Shiojima, Kenneth Walsh
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Apr 30, 2003·Nature Cell Biology·Carine BossardHervé Prats
Sep 3, 2003·Biochemical and Biophysical Research Communications·Jun-ichi OkanoYoshikazu Murawaki
Jan 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Toru KondoTetsuya Taga
Jul 13, 2004·Experimental Neurology·Maeve A CaldwellClive N Svendsen
Oct 12, 2004·Trends in Genetics : TIG·Nobuyuki Itoh, David M Ornitz
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
May 3, 2005·Cytokine & Growth Factor Reviews·Marco PrestaMarco Rusnati
Oct 21, 2005·Journal of Translational Medicine·Amy B HeimbergerKenneth Aldape
Jan 5, 2006·Brain Pathology·Ingeborg FischerDavid Zagzag
Mar 7, 2006·FEBS Letters·Petr DvorakAles Hampl
Apr 15, 2006·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Vigdis SørensenAntoni Wiedłocha
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
Jun 2, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Walid RachidiMichèle T Martin
Aug 7, 2008·Neuro-oncology·Claire Marie-Elisabeth SauvageotPatrick Yung Chih Wen
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Mar 10, 2009·Biochemical and Biophysical Research Communications·Matthieu SchoenhalsBernard Klein
Jan 23, 2010·Nature Reviews. Cancer·Nicholas Turner, Richard Grose
Apr 17, 2010·International Journal of Radiation Oncology, Biology, Physics·Lurong ZhangPaul Okunieff
Jan 5, 2011·Neuroscience Letters·Pedro CuevasGuillermo Giménez-Gallego
Nov 10, 2011·Neuro-oncology·Hiroaki WakimotoSamuel D Rabkin
Nov 16, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yonghyun KimDo-Hyun Nam
May 24, 2012·Cancer Research·Kyeung Min JooDo-Hyun Nam

❮ Previous
Next ❯

Citations

Feb 18, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yu-Chong PengLe-Qun Li
Mar 16, 2016·Stem Cells International·Elena CodriciCristiana Tanase
Apr 5, 2016·Cancers·Kevin KelleyRosamaria Ruggieri
Jun 29, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kai ZhouTing-Rong Zhang
Mar 17, 2020·Expert Opinion on Therapeutic Targets·Ana Jimenez-PascualJustin D Lathia
Nov 1, 2018·Reviews in the Neurosciences·Vasiliki Georgiou, Vasiliki Gkretsi
Nov 26, 2015·Journal of Neuro-oncology·Richard E KastMiguel Muñoz
Mar 11, 2016·Journal of Neuro-oncology·Lauriane HamardDidier Wion
Jun 12, 2016·Journal of Experimental & Clinical Cancer Research : CR·Jie TangZekuan Xu
Aug 23, 2019·Cancer Discovery·Ana Jimenez-PascualFlorian A Siebzehnrubl
Oct 20, 2018·Cancer Research·Damian A Almiron BonninMark A Israel
Mar 17, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hao ZhangHong Shen
Aug 8, 2021·International Journal of Molecular Sciences·Ximena VásquezVerónica Palma
Aug 3, 2021·Experimental Cell Research·Pritam Kumar RoyMahitosh Mandal
Jan 14, 2019·ACS Biomaterials Science & Engineering·Kottarapat JeenaManzoor Koyakutty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.